| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| IGIBi0011-A | Cell Lines | SCA12 | CVCL_D5AE |
PPP2R2B | 9/58 CAG | Institute of Genomics and Integrative Biology (CSIR-IGIB) |
| IGIBi002-A | Cell Lines | SCA12 | CVCL_VN63 |
PPP2R2B | 14/59 CAG | Institute of Genomics and Integrative Biology (CSIR-IGIB) |
| IGIBi003-A | Cell Lines | SCA12 | CVCL_VN64 |
PPP2R2B | 10/67 CAG | Institute of Genomics and Integrative Biology (CSIR-IGIB) |
| IGIBi004-A | Cell Lines | SCA12 | CVCL_VN65 |
PPP2R2B | 17/65 CAG | Institute of Genomics and Integrative Biology (CSIR-IGIB) |
| iHF SCA3 | Cell Lines | SCA3 | — |
ATXN3 | 23/67 CAG | University of Tübingen |
| II | Cell Lines | CANVAS | — |
RFC1 | AAGGGn expansion + C.2876 del | Massachusetts General Hospital and Harvard Medical School |
| III.4 (unaffected) | Cell Lines | SCA10 | — |
ATXN10 | 143/130 ATTCT repeats (pure repeat type, unaffected individual) | Stanford University School of Medicine |
| III.6 (unaffected) | Cell Lines | SCA10 | — |
ATXN10 | ?/? ATTCT repeats (pure repeat type, unaffected individual) | Stanford University School of Medicine |
| INNDSUi008-A | Cell Lines | SCA3 | CVCL_E4K5 |
ATXN3 | 67 CAG | Shandong University |
| INSRMe010-A | Cell Lines | SCA2 | CVCL_C088 |
ATXN2 | — | INSERM (INSRM) |
| iSCA2 E209-6, 9 | Cell Lines | SCA2 | CVCL_XI53, CVCL_XI54 |
ATXN2 | 44/22 CAG | Academia Sinica |
| iSCA2-17, 28 | Cell Lines | SCA2 | CVCL_XI51, CVCL_XI52 |
ATXN2 | 35/22 CAG | Academia Sinica |
| iSCA3 E149-10, 12 | Cell Lines | SCA3 | CVCL_XI57, CVCL_XI58 |
ATXN3 | 73/14 CAG | Academia Sinica |
| iSCA3-1, 36 | Cell Lines | SCA3 | CVCL_XI55, CVCL_XI56 |
ATXN3 | 70/37 CAG | Academia Sinica |
| IV.7 (unaffected) | Cell Lines | SCA10 | — |
ATXN10 | 271/49 ATTCT repeats (pure repeat type, unaffected individual) | Stanford University School of Medicine |
| JHUi003-A; Homozygous | Cell Lines | SCA12 | CVCL_A8HK |
PPP2R2B | 72/69 CAG; Homozygous line, CRISPR/Cas derived from: JHUi003-A; Heterozygous | Johns Hopkins University |
| JHUi004-A | Cell Lines | SCA12 | — |
PPP2R2B | 14/73 CAG; CRISPR/Cas modified from JHUi004-A; Ctrl line | Johns Hopkins University |
| JHUi004-A; Ctrl line | Cell Lines | SCA12 | — |
PPP2R2B | 14/10 CAG; parental line of: JHUi004-A | Johns Hopkins University |
| JUCTCi002-A | Cell Lines | AOA1 | — |
APTX | c.837G > A (p.Trp279Ter) (homozygous) | The University of Jordan |
| JUCTCi002-A, -B, -C | Cell Lines | AOA1 | CVCL_A9I3, CVCL_A9I4, CVCL_A9I5 |
APTX | c.837G > A (p.Trp279Ter) (homozygous) | The University of Jordan |
| KCGMHi003-A | Cell Lines | SCA8 | — |
ATXN8 or ATXN8OS | >70 CTG repeats | Kaohsiun chang Gung Memorial Hospital |
| Kcna-/- mice | Mouse Models | EA1 | — |
KCNA1 | Homozygous Kcna1 knockout | University of Washington |
| Kcna1V408A/+ | Mouse Models | EA1 | — |
KCNA1 | Heterozygous V408A mutation in the Kcna1 gene | Oregon Health & Sciences University |
| Kcnd3 F227del mutant mice | Mouse Models | SCA19/22 | — |
KCND3 | Knock-in of Kcnd3 F227del, both heterozygous and homozygous | National Yang Ming Chiao Tung University |
| Kcnd3 KO mice | Mouse Models | SCA19/22 | — |
KCND3 | Knockout of Kcnd3 | National Yang Ming Chiao Tung University |
| KOLF2.1J COQ2 M128V REV/WT | Cell Lines | MSA/OPCA | CVCL_E7K6 |
COQ2 | CRISPR/Cas9 engineered revertant of the heterozygously edited COQ2 p.Met78Val | The Jackson Laboratory |
| KOLF2.1J COQ2 M128V SNV/SNV | Cell Lines | MSA/OPCA | CVCL_E7K7 |
COQ2 | CRISPR/Cas9 engineered homozygous edited COQ2 p.Met78Val | The Jackson Laboratory |
| KOLF2.1J COQ2 M128V SNV/WT | Cell Lines | MSA/OPCA | CVCL_E7K8 |
COQ2 | CRISPR/Cas9 engineered heterozygous edited COQ2 p.Met78Val | The Jackson Laboratory |
| KOLF2.1J KCNC3 R420H REV/WT | Cell Lines | SCA13 | CVCL_E7LC |
KCNC3 | Control cell line: CRISPR/Cas9 revertant of KOLF2.1J KCNC3 R420H SNV/WT | The Jackson Laboratory |
| KOLF2.1J KCNC3 R420H SNV/SNV | Cell Lines | SCA13 | CVCL_E7LD |
KCNC3 | CRISPR/Cas9 edited from parental line; KCNC3 c.1259G>A (homozygous; p.Arg420His) | The Jackson Laboratory |
| KOLF2.1J KCNC3 R420H SNV/WT | Cell Lines | SCA13 | CVCL_E7LE |
KCNC3 | CRISPR/Cas9 edited from parental line; KCNC3 c.1259G>A (heterozygous; p.Arg420His) | The Jackson Laboratory |
| KOLF2.1J PRKCG F643L REV/WT | Cell Lines | SCA14 | CVCL_E7LY |
RKCG | CRISPR/Cas9 engineered revertant of the heterozygously edited PRKCG p.Phe643Leu (c.1927T>C) | The Jackson Laboratory |
| KOLF2.1J PRKCG F643L SNV/SNV | Cell Lines | SCA14 | CVCL_E7LZ |
RKCG | CRISPR/Cas9 engineered homozygous edited PRKCG p.Phe643Leu (c.1927T>C) | The Jackson Laboratory |
| KOLF2.1J PRKCG F643L SNV/WT | Cell Lines | SCA14 | CVCL_E7M0 |
RKCG | CRISPR/Cas9 engineered heterozygous edited PRKCG p.Phe643Leu (c.1927T>C) | The Jackson Laboratory |
| KOLF2.1J SPTBN2 25.2kbdel DEL/DEL | Cell Lines | SCA5 | CVCL_E7NR |
SPTBN2 | Complete SPTBN2 knock-out using CRISPR/Cas9 | The Jackson Laboratory |
| L-10182 | Cell Lines | SCA28 | — |
AFG3L2 | c.2167G>A p.V723M c.1847A>G p.Y616C (comp. heterozygous); affected son of L-11388 | University of Lübeck |
| L-11388 | Cell Lines | SCA28 | — |
AFG3L2 | c.1847A>G p.Y616C (heterozygous); unaffected mother from L10182 | University of Lübeck |
| L7CGG90Fmr1 | Mouse Models | FXTAS | — |
FMR1 | Specific expression of CGG repeats in Fmr1 in Purkinje neurons | Baylor College of Medicine |
| LUMCi002-A, B and C | Cell Lines | SCA1 | CVCL_VE42, CVCL_VE43, CVCL_VE44 |
ATXN1 | 29/46 CAG | Leiden University Medical Center |
| LUMCi022-A, B and C | Cell Lines | SCA1 | CVCL_ZA11, CVCL_ZA12, CVCL_ZA13 |
ATXN1 | 30/47 CAG | Leiden University Medical Center |
| LUMCi023-A-1 | Cell Lines | SCA1 | — |
ATXN1 | 26/37 CAG | Leiden University Medical Center |
| LUMCi023-A-2 | Cell Lines | SCA1 | — |
ATXN1 | 26/42 CAG | Leiden University Medical Center |
| LUMCi023-A-3 | Cell Lines | SCA1 | — |
ATXN1 | 29/56 CAG | Leiden University Medical Center |
| LUMCi023-A-4 | Cell Lines | SCA1 | — |
ATXN1 | 42/48 CAG | Leiden University Medical Center |
| LUMCi032-A and B | Cell Lines | SCA1 | — |
ATXN1 | 32/50 CAG | Leiden University Medical Center |
| LUMCi034-A, B and C | Cell Lines | SCA1 | CVCL_VE43 |
ATXN1 | 30/51 CAG | Leiden University Medical Center |
| LUMCi051-A | Cell Lines | SCA7 | CVCL_D6SI |
ATXN7 | 10/61 CAG | Leiden University Medical Center |
| LUMCi051-B | Cell Lines | SCA7 | CVCL_D6SM |
ATXN7 | 10/63 CAG | Leiden University Medical Center |
| LUMCi052-A | Cell Lines | SCA7 | CVCL_D6SJ |
ATXN7 | 10/60 CAG | Leiden University Medical Center |
| LUMCi052-B | Cell Lines | SCA7 | CVCL_D6SK |
ATXN7 | 10/66 CAG | Leiden University Medical Center |
Twenty Twenty-Five
Designed with WordPress